Iparomlimab and Tuvonralimab Injection Combined With SBRT in Patients With Early-Stage Non-Small Cell Lung Cancer

NCT07379398 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

NSCLC

Interventions

DRUG: lparomlimab and Tuvonralimab Injection in Combination with SBRT

Sponsor

Tianjin Medical University Cancer Institute and Hospital